A new study published in the Journal of Allergy and Clinical Immunology (JACI) has suggested that the cause of eczema is due to a protein deficiency.
According to a study published in Nature journal, researchers in Australia have discovered two rare forms of melanoma that are not caused by sun exposure unlike the cutaneous melanoma that is strongly linked to UV radiation.
Skincare company UNIVERSKIN has released a new serum for consumers aimed at treating an array of skin conditions.
Skincare manufacturer Danné Montague-King (DMK) has launched three Fundamental Kits.
A clinical study conducted by global pharmaceutical company Allergan suggests that higher doses of Botox Cosmetic (onabotulinumtoxinA) to treat moderate to severe glabella lines produces greater duration of treatment effect.
Results of a new study indicate that Botox (onabotulinumtoxinA, Allergan) can be used to treat crow’s feet lines safely and effectively.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Bocouture, a botulinum neurotoxin type A treatment, in the UK for treatment of upper facial lines.
International pharmaceutical company Galderma has increased its investment in research and innovation, initiating six new Phase III and IV US aesthetic clinical trials.
Facial injectables market to be worth $17.2 billion by 2025
Financial services company SunLife has conducted a study which suggests that there is an increasing amount of Britons over the age of 50 feeling under pressure to stay looking young.